Detalhe da pesquisa
1.
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.
Cell
; 184(9): 2348-2361.e6, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33730597
2.
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera.
Cell
; 184(8): 2201-2211.e7, 2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33743891
3.
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.
Nat Immunol
; 22(5): 620-626, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33674800
4.
Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.
Nat Immunol
; 22(7): 928, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34017126
5.
Syrian hamster convalescence from prototype SARS-CoV-2 confers measurable protection against the attenuated disease caused by the Omicron variant.
PLoS Pathog
; 19(4): e1011293, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37014911
6.
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial.
Lancet
; 399(10319): 36-49, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34883053
7.
Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials.
Clin Exp Immunol
; 211(3): 280-287, 2023 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36729167
8.
Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial.
Lancet
; 398(10318): 2277-2287, 2021 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34774197
9.
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.
Lancet
; 397(10282): 1351-1362, 2021 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33798499
10.
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial.
Lancet
; 398(10318): 2258-2276, 2021 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34863358
11.
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.
Lancet
; 398(10303): 856-869, 2021 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34370971
12.
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
Lancet
; 396(10267): 1979-1993, 2021 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33220855
13.
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Lancet
; 396(10249): 467-478, 2020 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32702298
14.
A phase IV, multi-centre, randomized clinical trial comparing two pertussis-containing vaccines in pregnant women in England and vaccine responses in their infants.
BMC Med
; 19(1): 138, 2021 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34098951
15.
Differential immunogenicity of BNT162b2 or ChAdOx1 vaccines after extended-interval homologous dual vaccination in older people.
Immun Ageing
; 18(1): 34, 2021 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34416887
16.
Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator.
Clin Infect Dis
; 61(11): 1637-44, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26374816
17.
Detection of SARS-CoV-2 BA.2.86 by lateral flow devices.
Int J Infect Dis
; 139: 168-170, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38151115
18.
Interlaboratory comparison of a multiplex immunoassay that measures human serum IgG antibodies against six-group B streptococcus polysaccharides.
Hum Vaccin Immunother
; 20(1): 2330138, 2024 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38608170
19.
Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis.
Lancet Microbe
; 5(3): e216-e225, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38278167
20.
A Randomized Trial Assessing the Immunogenicity and Reactogenicity of Two Hexavalent Infant Vaccines Concomitantly Administered With Group B Meningococcal Vaccine.
Pediatr Infect Dis J
; 42(1): 66-73, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36476534